sb 203580 has been researched along with beryllium in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (beryllium) | Trials (beryllium) | Recent Studies (post-2010) (beryllium) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 2,656 | 19 | 475 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gillespie, M; Huang, Z; Li, L; Maier, LA; Mroz, PM | 1 |
1 other study(ies) available for sb 203580 and beryllium
Article | Year |
---|---|
p38 Mitogen-Activated Protein Kinase in beryllium-induced dendritic cell activation.
Topics: Aged; Berylliosis; Beryllium; CD40 Antigens; Cell Proliferation; Cytokines; Dendritic Cells; Enzyme Activation; Female; Granulomatous Disease, Chronic; Humans; Imidazoles; Interferon-gamma; Lymphocyte Activation; Male; MAP Kinase Signaling System; Middle Aged; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2014 |